Zimbabwe has turned down a significant American healthcare agreement valued at $367m (£272m) over five years over Washington's insistence on confidential data.
This move came to light following a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa believed the deal was "skewed".
An official spokesman has since clarified that the United States was demanding access to genetic material for research and profit while was unwilling to guarantee the resulting advantages from future medical innovations.
"We must now begin the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged continued talks to secure a agreement suitable to both sides so the country's critical HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a high court suspended a related deal with the US following legal challenges were raised about the security of citizens' medical information.
After returning to office last year, US President Donald Trump has drastically cut overseas assistance and closed the key foreign aid agency.
USAID had managed assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to enhance transparency and accountability.
Based on reports, Sixteen African countries have so far agreed to these new health pacts, representing over $18.3bn in new funding.
Details of the Rejected Agreement
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy via US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to surrender its genetic material and health information for a long time, without any equivalent guarantee of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," his statement read.
"Effectively, our country would supply the basic resources for scientific discovery with no assurance that the resulting innovations would be available to our people if a future disease outbreak emerge."
National Interest and Global Health
He also noted that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining systems already established through the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.
"This mechanism is designed to ensure that when a country contributes its data, the benefits – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
These objections over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage further dialogue with our US partners on how subsequent co-operation could be arranged in a manner that respects the sovereignty and interests of each country."
Health Experts Response
Medical experts expressed it understood the government's concerns, but recommended that negotiations need to persist considering much of the country's Aids initiatives were funded by international support.
"In cases where technical issues exist, such as those relating to information security or agreement terms, these can frequently be resolved via technical clarification and negotiated safeguards," it added.
This impasse highlights the continuing challenges between accepting much-needed foreign assistance and protecting a country's data in an increasingly interconnected world.